Organization · Grant Maker
Washington Research Foundation
The Washington Research Foundation is a nonprofit organization based in Seattle that supports early-stage companies and advances research in Washington state, particularly in life sciences and enabling technologies.
Overview
What Washington Research Foundation does
What Washington Research Foundation is
The Washington Research Foundation is a nonprofit organization based in Seattle that supports early-stage companies and advances research in Washington state, particularly in life sciences and enabling technologies.
How it participates in the startup ecosystem
The current public profile supports funder and grantor capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Grant Maker
- Founded
- Founded in 1981
- Approximate age
- About 45 years
- Structured capabilities
- Funder · Grantor
- Last reviewed
- March 28, 2026
Official channels
Find Washington Research Foundation elsewhere
Open the official website or a supported primary organization account.
Capability profile
Washington Research Foundation as a funder
Investment thesis
The Washington Research Foundation supports innovative academic research, particularly in life sciences and enabling technologies, by facilitating the commercialization of discoveries.
Focus narrative
WRF invests in early-stage startups and provides grants to support research in life sciences and enabling technologies at nonprofit institutions in Washington state. Their funding aims to bridge the gap between discovery research and commercial investment, focusing predominantly on products and services in these sectors.
Value beyond capital
WRF provides funding and grants to support research and development, helping to bridge the gap between discovery and commercialization for innovative projects in life sciences and enabling technologies.
Focus and fit
- Stages
- Seed · Seed+ · Series A
- Regions
- United States
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 3
- Recorded notable exits
- Athira Pharma
Portfolio context
Notable portfolio companies include 2Morrow, which focuses on evidence-based behavioral change programs aimed at improving lives; Phase Genomics, which has received $3.9 million in grants to enhance testing for chromosomal abnormalities; and Athira Pharma, which raised $204 million in an IPO to advance treatments for Alzheimer's and other diseases.
Capability profile
Washington Research Foundation as a grantor
Grant thesis
The Washington Research Foundation supports innovative academic research, particularly in life sciences and enabling technologies, by providing grants to facilitate commercialization.
Focus narrative
The Washington Research Foundation invests in early-stage startups and provides grants to support research in life sciences and enabling technologies at nonprofit institutions in Washington state. Their funding aims to bridge the gap between discovery research and commercial investment, focusing predominantly on products and services in these fields.
Value and support
Beyond funding, WRF collaborates with scientists and researchers to facilitate the commercialization of their discoveries, providing support that bridges research and market application.
Grant economics
- Dilutive
- No
- Nonprofit only
- Yes
Availability
- Next deadline
- May 1, 2026
Eligibility and fit
- Stages
- Pre-seed · Seed
- Audience
- Researchers
- Regions
- United States
Process and recipient context
Application process
WRF offers various programs, including Postdoctoral Fellowships and Technology Commercialization Grants. The application for the next cohort of Postdoctoral Fellowships opens on May 1, 2026. Interested parties can submit proposals through the WRF website.
Recipient context
Notable portfolio companies include 2Morrow, which focuses on evidence-based behavioral change programs; Phase Genomics, which has received $3.9 million in grants for testing chromosomal abnormalities; and Athira Pharma, which raised $204 million in an IPO for Alzheimer's treatments.
Common questions
What to know about Washington Research Foundation
Upseed classifies Washington Research Foundation under the Grant Maker organization type. Its current public profile includes funder and grantor capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 28, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.